Sanofi, Capgemini, Generali and Orange Announce the Creation of a Digital Ecosystem Dedicated to E-health
The StreetInsider reported that Sanofi, Capgemini, Generali and Orange announced plans to create a joint venture in France to fast-track the development of concrete healthcare solutions and to make them available to the market for the benefit of patients. The project, on a scale that is unique in Europe, will bring together leading scientific and technological
Comments Off on Sanofi, Capgemini, Generali and Orange Announce the Creation of a Digital Ecosystem Dedicated to E-health • Read this story »
More Articles
Sanofi Announces AfricaTech 2020 Challenge
The Guardian website reported that Sanofi, a global biopharmaceutical company, is calling on technology entrepreneurs and startups in Nigeria to participate in its 2020 AfricaTech Challenge. AfricaTech is a lab to encourage open innovation by African technology startups. The AfricaTech Challenge
Comments Off on Sanofi Announces AfricaTech 2020 Challenge • Read this story »
Evotec, Sanofi on Infectious Disease Research Agreement
The Pharmaceutical Business Review website reported that the major drug companies Evotec and Sanofi are in exclusive negotiations to create an infectious disease open innovation research and development platform through a new open innovation platform near Lyon in France. The platform will be led by
Comments Off on Evotec, Sanofi on Infectious Disease Research Agreement • Read this story »
Korean Drugmakers to Seek Global Partnerships
The Korea Herald website reported that South Korean pharmaceutical companies and global drugmakers came together to discuss new business partnerships and open innovation at this year’s Korea Pharma Associations Conference in Seoul. As one of the biggest pharma industry events of the year, the conference
Comments Off on Korean Drugmakers to Seek Global Partnerships • Read this story »
Sanofi Feeds on the Scientific Richness of Boston
The Quebec Telegram website reported the development of Sanofi, a major life sciences firm in Boston. In 2011 the company completely restructured its R & D laboratory and converted it to the “open innovation” model – adopted today by most major laboratories; a change dictated by the urgency
Comments Off on Sanofi Feeds on the Scientific Richness of Boston • Read this story »
Global Drugmakers Join Hands With Startups
The Yonhapnews website reported that global pharmaceutical companies are seeking to join hands with local startups as part of their effort to increase research and development productivity. The move is part of their effort to adopt “open innovation,” a network of collaboration with external
Comments Off on Global Drugmakers Join Hands With Startups • Read this story »
Deloitte: Open Innovation Success Rate 3 Times Higher Than In-house R&D
The Knowledge website reported that the knowledge intensity and speed of biotechnology has shifted the locus of innovation to a network rather than within any single firm. This is causing pharmaceutical firms to look for new ways to tap into innovative sources of drug development outside their organizational
Comments Off on Deloitte: Open Innovation Success Rate 3 Times Higher Than In-house R&D • Read this story »
Open Innovation and Big Pharma
The PMLive website reported that there has been a major drive towards an open innovation model among big pharma companies, seeking to forge closer ties with small biopharma companies and academic groups in recognition that relying on in-house pharma R&D is no longer enough to remain competitive.
Comments Off on Open Innovation and Big Pharma • Read this story »
Changing the Model for Pharma Innovation
The PharmTech website noted that at this point, for many companies, results suggest that the desire and commitment to open innovation may be there, but questions of risk and reward remain. For now, for many companies, open innovation is a work in progress, but the factors driving this trend are not
Comments Off on Changing the Model for Pharma Innovation • Read this story »
Open Innovation to Fill Pharma’s Pipelines
The medcitynews website reported that open innovation and cooperation in the pharmaceutical industry will continue to gain traction as patent losses and R&D cutbacks force drug companies to look